Background: Attention deficit/hyperactivity disorder (ADHD) is a common childhood neuropsychiatric disorder. Autonomic nervous system plays a vital role in attention, self-regulation, emotional stability and social affiliation, which are affected in ADHD. The prefrontal cortex, which is vital for attention, motor control, emotional regulation and higher order autonomic control, is hypofunctional in ADHD. In addition, catecholamine dysregulation is there. Purpose: We hypothesized that there is autonomic dysfunction: reduction in overall heart rate variability (HRV) and sympathovagal imbalance in children with ADHD. Methods: Study criteria were drug-naïve ADHD children who were 7-12 years of age of either gender who fulfilled DSM-IV criteria for ADHD and did not have any associated comorbid psychiatric/neurological/medical disorders. Two hundred and seventy ADHD children were screened out of which only 12 were found eligible and 10 participated. Sample size was 20 (cases = 10, age- and gender-matched healthy controls = 10). Short-term HRV of both time and frequency domains were assessed by recording lead II electrocardiogram after using Tell-Show-Do, a behavior shaping technique. Comparison between groups was done using Mann-Whitney and Wilcoxon test. Demographic variables like age, height, weight and body mass index were similar between groups. Results: Among time domain parameters, SD of all NN intervals, square root of the mean of the sum of squares of differences between adjacent NN intervals and percentage of count of number of pairs of adjacent NN intervals differing by more than 50 ms were reduced in ADHD group with p < 0.05. Among frequency domain parameters, total power was reduced in ADHD group with p < 0.05, high frequency power (HF) was reduced in ADHD group with p < 0.01 and low frequency power to HF ratio was higher in ADHD group with p < 0.01. Conclusion: There is autonomic dysfunction in children with ADHD - reduction in overall HRV with sympathovagal imbalance with sympathetic dominance.

Keywords:
Prefrontal cortex, Smart vagus, Heart rate variability , Sympathovagal balance, Autonomic dysfunction, Attention-deficit/hyperactivity disorder
1.
Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S: ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1007-1022.
2.
Rash JA, Aguirre-Camacho A: Attention-deficit hyperactivity disorder and cardiac vagal control: a systematic review. Atten Defic Hyperact Disord 2012;4:167-177.
3.
Martin A, Volkmar FR, Lewis M: Lewis's Child and Adolescent Psychiatry: A Comprehensive Textbook, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2007.
4.
Gozal D, Molfese DL: Attention Deficit Hyperactivity Disorder: From Genes to Patients. New Jersey, Humana Press, 2005.
5.
Tripp G, Wickens JR: Neurobiology of ADHD. Neuropharmacology 2009;57:579-589.
6.
Arnsten AF: The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex. J Pediatr 2009;154:I-S43.
7.
Benarroch EE: The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988-1001.
8.
Low PA, Benarroch EE: Clinical Autonomic Disorders, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2008.
9.
Curatolo P, D'Agati E, Moavero R: The neurobiological basis of ADHD. Ital J Pediatr 2010;36:79.
10.
Beauchaine TP, Gatzke-Kopp L, Mead HK: Polyvagal theory and developmental psychopathology: emotion dysregulation and conduct problems from preschool to adolescence. Biol Psychol 2007;74:174-184.
11.
Porges SW: The polyvagal perspective. Biol Psychol 2007;74:116-143.
12.
Porges SW: The polyvagal theory: new insights into adaptive reactions of the autonomic nervous system. Cleve Clin J Med 2009;76(suppl 2):S86-S90.
13.
Malik M: Clinical Guide to Cardiac Autonomic Tests. Dordrecht, Kluwer Academic Publishers, 1998.
14.
Yamada T: Tachycardia. New York, Intech, 2012.
15.
Kemp AH, Quintana DS: The relationship between mental and physical health: insights from the study of heart rate variability. Int J Psychophysiol 2013;89:288-296.
16.
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Eur Heart J 1996;17:354-381.
17.
Malik M, Cramm AJ: Dynamic Electrocardiography. New York, Futura, 2004.
18.
Udupa K, Sathyaprabha TN, Thirthalli J, et al: Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures. J Affect Disord 2007;100:137-141.
19.
Shibagaki M, Furuya T: Baseline respiratory sinus arrhythmia and heart-rate responses during auditory stimulation of children with attention-deficit hyperactivity disorder. Percept Mot Skills 1997;84(3 pt 1):967-975.
20.
Beauchaine TP, Katkin ES, Strassberg Z, et al: Disinhibitory psychopathology in male adolescents: discriminating conduct disorder from attention-deficit/hyperactivity disorder through concurrent assessment of multiple autonomic states. J Abnorm Psychol 2001;110:610-624.
21.
Buchhorn R, Conzelmann A, Willaschek C, et al: Heart rate variability and methylphenidate in children with ADHD. Atten Defic Hyperact Disord 2012;4:85-91.
22.
Buchhorn R, Müller C, Willaschek C, et al: How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD. ISRN Pharmacol 2012;2012:170935.
23.
Musser ED, Backs RW, Schmitt CF: Emotion regulation via the autonomic nervous system in children with attention-deficit/hyperactivity disorder (ADHD). J Abnorm Child Psychol 2011;39:841-852.
24.
Börger N, van der Meere J, Ronner A, et al: Heart rate variability and sustained attention in ADHD children. J Abnorm Child Psychol 1999;27:25-33.
25.
Crowell SE, Beauchaine TP, Gatzke-Kopp L, et al: Autonomic correlates of attention-deficit/hyperactivity disorder and oppositional defiant disorder in preschool children. J Abnorm Psychol 2006;115:174-178.
26.
Negrao BL, Bipath P, van der Westhuizen D, et al: Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate. Neuropsychobiology 2011;63:82-91.
27.
Wang TS, Huang WL, Kuo TB, et al: Inattentive and hyperactive preschool-age boys have lower sympathetic and higher parasympathetic activity. J Physiol Sci 2013;63:87-94.
28.
Lackschewitz H, Hüther G, Kroner-Herwig B: Physiological and psychological stress responses in adults with attention-deficit/hyperactivity disorder (ADHD). Psychoneuroendocrinology 2008;33:612-624.
29.
Yang AC, Hong CJ, Tsai SJ: Heart rate variability in psychiatric disorders. Taiwanese J Psychiatr (Taipei) 2010;24:99-109.
30.
Jansen K, Lagae L: Cardiac changes in epilepsy. Seizure 2010;19:455-460.
31.
Axelrod F, Chelimsky GG, Weese-Mayer DE: Pediatric autonomic disorders. Pediatrics 2007;118:309-321.
32.
American Academy of Pediatric Dentistry: Guideline on Behavior Guidance for the Pediatric Dental Patient. Reference Manual, 2011, vol 34, pp 170-182.
33.
Kim HS, Yoon KH, Cho JH: Diurnal heart rate variability fluctuations in normal volunteers. J Diabetes Sci Technol 2014;8:431-433.
34.
Baek J, Park D, Kim I, et al: Autonomic dysfunction of overweight combined with low muscle mass. Clin Auton Res 2013;23:325-331.
35.
McCarthy H, Skokauskas N, Frodl T: Identifying a consistent pattern of neural function in attention deficit hyperactivity disorder: a meta-analysis. Psychol Med 2014;44:869-880.
36.
Coffey CW, Brumback RA: Pediatric Neuropsychiatry. Philadelphia, Lippincott Williams & Wilkins, 2006.
37.
Tasman A, Kay J, Lieberman JA: Psychiatry, ed 2. Chichester, John Wiley & Sons, 2003.
38.
Martinez-Raga J, Knecht C, Szerman N, et al: Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs 2013;27:15-30.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.